Hugo Goitia, MD
Family Medicine · Milwaukee, WINPI 1417121153
Payments from drug & device makers
Across 47 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$320
- Lundbeck LLC$73
- Neurocrine Biosciences, Inc.$69
- Otsuka America Pharmaceutical, Inc.$54
- Vanda Pharmaceuticals Inc.$51
- Johnson & Johnson$43
- plus $211 from 10 others
What the payments were for
- Food & beverage$80898%
- Education$142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $320 |
| Lundbeck LLC | 4 | $73 |
| Neurocrine Biosciences, Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| Johnson & Johnson | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Pfizer | 1 | $30 |
| Indivior Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Exact Sciences | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
How this compares
$822 in reported general payments places this provider in the 85th percentile of 1,482 family medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Haloperidol | 11 | $1,348 |
| Trazodone Hcl | 57 | $761 |
| Ziprasidone Hcl | 20 | $648 |
| Atomoxetine Hcl | 12 | $576 |
| Gabapentin | 44 | $512 |
| Buspirone Hcl | 45 | $496 |
| Celecoxib | 17 | $450 |
| Hydroxyzine Hcl | 17 | $449 |
| Duloxetine Hcl | 17 | $367 |
| Bupropion XlBupropion Hcl | 23 | $329 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $302 |
| Atorvastatin Calcium | 40 | $301 |
| Omeprazole | 26 | $250 |
| Clonazepam | 15 | $219 |
| Mirtazapine | 20 | $190 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Milwaukee
- William PalinMilwaukee$693K
- Mario KapetsonisMilwaukee$123K
- Syed AhmedMilwaukee$78K
- Steven BondowMilwaukee$34K
- Suresh MisraMilwaukee$16K
- Ramneet BhathalMilwaukee$12K
- Roland WillockMilwaukee$7K
- Taha El-ShahatMadison$15.6M
- Jonathan MeimanMadison$4.3M
- John AgaibyKenosha$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.